|
|
 |
|
Viewing report
|
|
|
|
Active Delivery Systems for OTC Drugs: Opportunity in Innovation
Kline & Company, Inc., Jan 2008, Pages: 31
Active delivery systems, also known as targeted drug delivery systems, have introduced innovative ways to deliver actives in prescription pharmaceuticals for some time now. The shift from a 'mass delivery' protocol to 'optimized delivery' that started over 20 years ago is often attributed to the evolution of patches as a means of delivering actives. Now there is a wide range of novel delivery systems for many actives.
The need to deliver an active agent optimally to its site of action is so important that an entire section of the drug development industry caters to meeting this end. New delivery forms and systems continue to be introduced in an effort to boost the efficacy of medications, differentiate products from their competitors, better leverage advancing technologies, and improve convenience for the consumer.
Why Buy this Report?
The potential exists for even greater innovation in new systems delivering actives to almost every part of the human body, which can give OTC companies improved efficacy and market differentiation. Furthermore, drug delivery companies will find expanded market opportunities.
This report examines the strategic implications of these market developments and covers the following topics:
- Factors influencing the business
- Consumer buying characteristics
- Demand drivers
- Barriers to entry
- Noteworthy actives
- Innovations and technologies in active delivery systems for OTC drugs
- Competitive landscape
Benefits of Active Delivery Systems
This section presents a description of benefits derived from the use of active delivery systems, such as the management of “pill burden” and “optimized delivery,” including chronotherapeutics.
Market Overview
This section presents a description of the U.S. market in terms of dollar values and reasons why Rx active delivery system companies are not too keen on exploring the OTC side of the business
Consumer Purchase Motivation
This section explains why consumers buy OTC drugs with new active delivery systems. The findings will be compiled from Kline’s primary research and assessment of some secondary sources.
Competitive Landscape
This section first gives a big-picture description of the competitive scenario with regard to the keys to success. A snapshot is then provided for about 10 key companies (both Rx and OTC) from various countries that are either generating landmark products or have made important contributions to the growth and development of the entire field, setting one or more “gold standards” for the entire industry.
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
Prescription Drug Patches to 2015: Products, Indications, Markets and Opportunities
Successful Strategies for Pharmaceutical Reformulation
Transdermal Drug Delivery - Technologies, Markets, and Companies
Next Generation Transdermal Drug Patches: Evolving Technology, Emerging Opportunities
Intranasal Drug Delivery - Global Strategic Business Report
Drug Delivery in Cancer - Technologies, Markets and Companies
Pediatric Drug Delivery: Technology and Product Opportunities, 2nd Edition
Top 10 Drug Delivery Technologies (2010 - 2015)
Transmucosal Drug Delivery: Markets & Prospects for Films, Sprays, Lozenges, Wafers & Tablets
Cardiovascular Drug Delivery - Technologies, Markets and Companies
|
|
|
|
